Teva Pharma (TEVA) PT Raised to $15 at Argus
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $36.52 -0.6%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Teva Pharma (NYSE: TEVA) to $15.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $42 at Barclays
- Applied Aerospace & Defense (AADX) PT Lowered to $23 at BofA Securities
- Galaxy Entertainment Group Ltd (27:HK) (GXYEF) PT Lowered to HK$43.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
